Elizabeth Akoth

639 total citations
10 papers, 257 citations indexed

About

Elizabeth Akoth is a scholar working on Hepatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Elizabeth Akoth has authored 10 papers receiving a total of 257 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Hepatology, 5 papers in Epidemiology and 2 papers in Infectious Diseases. Recurrent topics in Elizabeth Akoth's work include Hepatitis C virus research (7 papers), Liver Disease Diagnosis and Treatment (4 papers) and Hepatitis B Virus Studies (2 papers). Elizabeth Akoth is often cited by papers focused on Hepatitis C virus research (7 papers), Liver Disease Diagnosis and Treatment (4 papers) and Hepatitis B Virus Studies (2 papers). Elizabeth Akoth collaborates with scholars based in United States and Malaysia. Elizabeth Akoth's co-authors include Chloe Gross, Sarah Kattakuzhy, Rachel Silk, Shyam Kottilil, Henry Masur, Elana Rosenthal, Lydia Tang, Eleanor Wilson, Angie Price and Gebeyehu Teferi and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Internal Medicine and Clinical Infectious Diseases.

In The Last Decade

Elizabeth Akoth

10 papers receiving 251 citations

Peers

Elizabeth Akoth

HEPAT

EPIDE

EDM

GHP

Ahmed F. Sherief Egypt

C. Hézode France

Gebeyehu Teferi United States

Kerry Townsend United States

Antonio Carlotto Italy

Peter Bramley United Kingdom

Jenny Bischoff Germany

V Thibaut France

Sheila Tumilty United States

Manuela Curescu Romania

Ahmed F. Sherief Egypt

Elizabeth Akoth

165 ×0.7

HEPAT

167 ×0.8

EPIDE

54 ×1.3

8 ×0.6

EDM

4 ×0.5

GHP

Citations per year, relative to Elizabeth Akoth Elizabeth Akoth (= 1×) peers Ahmed F. Sherief

Countries citing papers authored by Elizabeth Akoth

Since Specialization

Citations

This map shows the geographic impact of Elizabeth Akoth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth Akoth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth Akoth more than expected).

Fields of papers citing papers by Elizabeth Akoth

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elizabeth Akoth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth Akoth. The network helps show where Elizabeth Akoth may publish in the future.

Co-authorship network of co-authors of Elizabeth Akoth

This figure shows the co-authorship network connecting the top 25 collaborators of Elizabeth Akoth. A scholar is included among the top collaborators of Elizabeth Akoth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizabeth Akoth. Elizabeth Akoth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Xie, Changqing, Elizabeth Akoth, Bernadette Redd, et al.. (2021). A pilot study of the combination of checkpoint inhibition with ablation in subjects with biliary tract cancer.. Journal of Clinical Oncology. 39(15_suppl). e16150–e16150. 3 indexed citations

Monge, Cecilia, Changqing Xie, Gagandeep Brar, et al.. (2020). A phase I/II study of JX-594 oncolytic virus in combination with immune checkpoint inhibition in refractory colorectal cancer. European Journal of Cancer. 138. S57–S58. 6 indexed citations

Xi, Liqiang, Constance M. Cultraro, Fengcai Wei, et al.. (2019). P1.01-27 Serial Circulating Tumor DNA (ctDNA) Analysis of Blood and Saliva Predicts Osimertinib Response and Resistance in EGFR-Mutant NSCLC. Journal of Thoracic Oncology. 14(10). S366–S366. 1 indexed citations

Akoth, Elizabeth, Chloe Gross, Rachel Silk, Elana Rosenthal, & Sarah Kattakuzhy. (2017). A Practical Approach and Model of Care for HCV Treatment With Direct Acting Antivirals in an Urban Setting. Journal of the Association of Nurses in AIDS Care. 28(5). 680–684. 1 indexed citations

Chairez, Cheryl, Elizabeth Akoth, Chloe Gross, et al.. (2017). No Improvement in Hemoglobin A1c Following Hepatitis C Viral Clearance in Patients With and Without HIV. The Journal of Infectious Diseases. 217(1). 47–50. 28 indexed citations

Kattakuzhy, Sarah, Chloe Gross, Benjamin Emmanuel, et al.. (2017). Expansion of Treatment for Hepatitis C Virus Infection by Task Shifting to Community-Based Nonspecialist Providers. Annals of Internal Medicine. 167(5). 311–318. 166 indexed citations

Gross, Chloe, Elizabeth Akoth, Angie Price, et al.. (2016). HIV/HCV Co-infection: Overcoming Barriers to Treatment. Journal of the Association of Nurses in AIDS Care. 27(4). 524–529. 4 indexed citations

Wilson, Eleanor, Sarah Kattakuzhy, Sreetha Sidharthan, et al.. (2015). Successful Retreatment of Chronic HCV Genotype-1 Infection With Ledipasvir and Sofosbuvir After Initial Short Course Therapy With Direct-Acting Antiviral Regimens. Clinical Infectious Diseases. 62(3). 280–288. 38 indexed citations

Kattakuzhy, Sarah, Sreetha Sidharthan, Eleanor Wilson, et al.. (2015). P0875 : Predictors of sustained viral response to 4–6 week duration therapy with ledipasvir + sofosbuvir + GS-9451 +/− GS-9669 in early and advanced fibrosis (NIH/UMD synergy trial). Journal of Hepatology. 62. S669–S669. 6 indexed citations

10.

Wilson, Eleanor, Sarah Kattakuzhy, Zayani Sims, et al.. (2015). LP09 : High efficacy of retreatment with ledipasvir and sofosbuvir in HCV patients who failed initial short course therapy with combination DAA regimens (nih synergy trial). Journal of Hepatology. 62. S267–S268. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact